Dr. Kleopas is a Senior Consultant Neurologist and Professor, currently heading the Neuroscience Department and acting as Head of the Neuropathology Department at The Cyprus Institute of Neurology and Genetics. He coordinates the Neuroscience Graduate Program and the Center for Neuromuscular Disorders and Multiple Sclerosis. Dr. Kleopas has made significant contributions to understanding inherited neuropathy and leukodystrophy, pioneering cell-targeted gene therapy for demyelinating neurological diseases. His work on X-linked Charcot-Marie-Tooth Disease and CMT4C has led to groundbreaking gene therapy methods using viral vectors. He has published over 80 peer-reviewed papers and received numerous awards, including the European Academy of Neurology Investigator Award for his research on gene therapy. Dr. Kleopas is recognized for his leadership in neurology research, education, and clinical practice.

Dr. Alex Fay is a pediatric neurologist specializing in neuromuscular diseases such as muscular dystrophy, spinal muscular atrophy, Charcot-Marie-Tooth disease, and myasthenia gravis. He works collaboratively with experts in various fields to offer comprehensive care for children with these disorders, aiming to help them maintain health and reach their full potential. Dr. Fay focuses on the genetics of childhood-onset neuromuscular disorders. A Bay Area native, Dr. Fay earned his doctoral degree in biophysics and medical degree from UCSF.He completed his residency in pediatric neurology and fellowship in neuromuscular medicine at Washington University School of Medicine in St. Louis. Dr. Fay is a member of the American Academy of Neurology and Child Neurology Society.He was awarded the Child Neurologist Career Development K-12 Award from the National Institutes of Health in 2016.

Dr. Shy is a certified Neurologist trained at Columbia Presbyterian Medical Center in New York. He specializes in neuromuscular diseases and holds positions as Professor of Neurology, Pediatrics, and Molecular Physiology and Biophysics at the University of Iowa. Dr. Shy established the first specialized Charcot Marie Tooth (CMT) clinic at Wayne State University in Detroit. As Director of the Neuromuscular and Neurogenetics Divisions, he leads research funded by the National Institutes of Health, Muscular Dystrophy Association, and Charcot Marie Tooth Association. He heads the Inherited Neuropathy Consortium within the Rare Disease Clinical Research Network, overseeing care for 6,000 individuals with CMT. Dr. Shy's work primarily focuses on inherited peripheral neuropathies, with over 250 published manuscripts.He aims to develop rational therapies for these conditions through translational research.